HomeInsightsStock Comparison

Kms Medisurgi Ltd vs Transgene Biotek Ltd Stock Comparison

Kms Medisurgi Ltd vs Transgene Biotek Ltd Stock Comparison

Last Updated on: Jul 04, 2025

Key Highlights

  • The Latest Trading Price of KMS Medisurgi Ltd is ₹ 126.9 as of 27 Jun 15:30.
  • The P/E Ratio of KMS Medisurgi Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of KMS Medisurgi Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 22.81 crore on March 2020 to ₹ 61.68 crore on March 2024 . This represents a CAGR of 22.01% over 5 years.
  • The revenue of KMS Medisurgi Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Transgene Biotek Ltd for the Mar '25 is ₹ 0.12 crore as compare to the Dec '24 revenue of ₹ 0.12 crore. This represent the decline of 0%.
  • The ebitda of KMS Medisurgi Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Transgene Biotek Ltd for the Mar '25 is ₹ -0.5 crore as compare to the Dec '24 ebitda of ₹ -0.05 crore. This represent the growth of 900%.
  • The net profit of KMS Medisurgi Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Transgene Biotek Ltd changed from ₹ -0.13 crore to ₹ -0.71 crore over 8 quarters. This represents a CAGR of 133.70% .
  • The Dividend Payout of KMS Medisurgi Ltd changed from 15 % on March 2020 to 3.67 % on March 2024 . This represents a CAGR of -24.54% over 5 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About KMS Medisurgi Ltd

  • KMS Medisurgi Limited was incorporated as 'KMS Medisurgi Private Limited' on March 25, 1999 at Mumbai.
  • The Company converted into a Public Limited Company and name was changed to 'KMS Medisurgi Limited' on June 15, 2016. The Company manufactures & undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive.
  • It is engaged in the business of ethical marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipments, Surgery Equipments, Orthopedic/Physiotherapy Equipments, Blood Banking Equipments and other such Surgical Equipments in India. The Company was established in 1999 as surgical equipment company and since then it has been launching new concepts which helped the Indian Healthcare industry.

About Transgene Biotek Ltd

  • Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India.
  • Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
  • The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

KMS Medisurgi Ltd News Hub

News

KMS Medisurgi to conduct board meeting

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 27 June 2025...

Read more

20 Jun 2025 13:39

News

KMS Medisurgi to table results

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 30 May 2025....

Read more

24 May 2025 13:48

News

KMS Medisurgi to hold board meeting

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

12 Nov 2024 14:12

News

Board of KMS Medisurgi recommends final dividend

KMS Medisurgi announced that the Board of Directors of the Company at its meeting held on ...

Read more

28 Aug 2024 17:43

News

KMS Medisurgi to hold AGM

KMS Medisurgi announced that the 26th Annual General Meeting (AGM) of the company will be ...

Read more

28 Aug 2024 17:43

News

KMS Medisurgi to consider Dividend

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 28 August 20...

Read more

20 Aug 2024 16:27

Transgene Biotek Ltd News Hub

News

Transgene Biotek announces board meeting date

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 7 May 202...

Read more

28 Apr 2025 09:22

News

Transgene Biotek declare Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 24 Januar...

Read more

17 Jan 2025 11:58

News

Transgene Biotek to announce Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 12 Novemb...

Read more

05 Nov 2024 12:01

News

Transgene Biotek to hold board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 10 August...

Read more

20 Jul 2024 12:06

News

Transgene Biotek schedules board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 30 May 20...

Read more

13 May 2024 11:11

News

Transgene Biotek to conduct board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 14 Februa...

Read more

30 Jan 2024 14:56

SWOT Analysis Of Transgene Biotek Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of KMS Medisurgi Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Transgene Biotek Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for KMS Medisurgi Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of KMS Medisurgi Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, KMS Medisurgi Ltd or Transgene Biotek Ltd?

Market cap of KMS Medisurgi Ltd is 41 Cr while Market cap of Transgene Biotek Ltd is 35 Cr

What are the key factors driving the stock performance of KMS Medisurgi Ltd and Transgene Biotek Ltd?

The stock performance of KMS Medisurgi Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for KMS Medisurgi Ltd and Transgene Biotek Ltd?

As of July 4, 2025, the KMS Medisurgi Ltd stock price is INR ₹126.9. On the other hand, Transgene Biotek Ltd stock price is INR ₹4.73.

How do dividend payouts of KMS Medisurgi Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of KMS Medisurgi Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions